Company Overview
Laird Superfood, Inc. operates as a manufacturer and marketer of plant-based natural and functional food products within the United States, offering a diverse portfolio that includes powdered and liquid coffee creamers, hydration supplements, coconut water, performance mushroom supplements, and various functional ingredients. The company is positioned within the Consumer Defensive sector and specifically operates in the Packaged Foods industry, a classification that typically suggests products essential to daily consumption, though the firm currently reports financial metrics inconsistent with mature defensive stocks. Laird Superfood maintains a market capitalization of $21.94M and generates annual revenue of $48.15M, supported by an organizational structure of 26 employees. These valuation and revenue figures indicate a small-cap enterprise operating with a lean workforce, suggesting that the company relies heavily on operational efficiency and product concentration to generate its reported sales volume. The disparity between the relatively modest market cap and the nearly $50 million in revenue highlights the market's cautious stance on the company's future earnings potential or the risks associated with its specific business model and growth trajectory.
Financial Health
The company reports a trailing twelve-month revenue of $48.15M, yet it simultaneously reports a net loss of $-1,891,869 and an EBITDA of $-1,177,408, revealing a cost structure where operating expenses significantly outweigh gross profits. The free cash flow stands at $-1,973,202, which indicates a negative cash generation capability that limits the company's financial flexibility and its ability to fund operations without external capital injection. Gross margins are established at 39.1%, reflecting the pricing power and cost of goods sold for the product mix, while operating margins sit at -2.6% and profit margins at -3.9%, indicating that overhead costs and non-operating expenses are eroding the bottom line to a significant degree. On the balance sheet, the company holds $5.40M in cash against a debt obligation of $179,152, resulting in a debt-to-equity ratio of 1.40, which suggests a leveraged position given that the debt exceeds the equity base implied by the ratio. The current ratio is reported at 3.08, signaling strong short-term liquidity relative to current liabilities, though this liquidity is currently being consumed by negative cash flows. Return on Equity is -14.6% and Return on Assets is -4.8%, metrics that reveal management is currently destroying value rather than generating returns on the capital deployed by shareholders and creditors.
Valuation Assessment
The valuation metrics present a complex picture with a P/E Ratio (TTM) listed as N/A due to the lack of net income, while the Forward P/E is -0.51, a negative multiple that implies the market expects earnings to remain negative or turn positive in the future but does not yet value the stock on trailing earnings. The Price to Book ratio is 1.71, suggesting the market is pricing the company at a 71% premium over its book value, which may reflect growth expectations or asset valuation discrepancies rather than current profitability. Alternative valuation measures include a Price to Sales ratio of 0.46 and an EV/EBITDA of -15.99, both of which indicate the stock is trading at a discount relative to sales but carry a significant negative earnings multiple that complicates traditional valuation comparisons. The 52-week high is $7.94 and the 52-week low is $1.97, meaning the stock has experienced substantial volatility over the last year with a trading range of nearly four times its lower bound. The Beta value is 2.47, which indicates that the stock price is highly volatile and tends to fluctuate with significantly greater magnitude than the broader market, exposing investors to elevated systematic risk.
Growth & Income
Revenue growth is reported at 9.5% year-over-year, demonstrating an expansion in sales volume, whereas earnings growth is listed as N/A because the company is currently unprofitable, implying that top-line growth has not yet translated into bottom-line profitability. The company does not pay a dividend, evidenced by a Dividend Yield of N/A and a Payout Ratio of 0.0%, meaning that all available cash flow is theoretically retained for operations, debt reduction, or reinvestment rather than being distributed to shareholders. Since the company is a non-dividend payer with negative earnings, the focus remains entirely on operational scaling and turning the current losses into profit rather than generating income through dividends. The overall growth and income profile is characterized by positive revenue expansion offset by persistent losses and a complete absence of dividend income, positioning the firm as a pure growth play dependent on future profitability to attract capital.